Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q96L34
UPID:
MARK4_HUMAN
Alternative names:
MAP/microtubule affinity-regulating kinase-like 1
Alternative UPACC:
Q96L34; Q8NG37; Q96JG7; Q96SQ2; Q9BYD8
Background:
MAP/microtubule affinity-regulating kinase 4, also known as MAP/microtubule affinity-regulating kinase-like 1, is a serine/threonine-protein kinase. It plays a crucial role in phosphorylating microtubule-associated proteins such as MAPT/TAU, MAP2, and MAP4, leading to the reorganization of microtubules into bundles. This kinase is essential for axoneme extension during cilium assembly and influences cell cycle progression, particularly at the G1/S checkpoint. It also impacts neuronal cell survival, energy homeostasis, adipogenesis, and apoptosis through various signaling pathways.
Therapeutic significance:
Understanding the role of MAP/microtubule affinity-regulating kinase 4 could open doors to potential therapeutic strategies.